baber/WOPTO huggingface dataset:
Patent NZ-554897-A (NZ)
Title: Arthrospira-based compositions and uses thereof
Inventor: DUNCAN KELVIN WINSTON
IPC: A01N63/20
Filed: 2005-11-03
Abstract: Disclosed is a composition comprising physiologically stressed Arthrospira maxima for use as a biocide and/or therapeutic and the method for preparing said Arthrospira. Also disclosed is a use of the fore mentioned Arthrospira in the manufacture of a medicament for treating skin infections.
Patent NZ-556162-A (NZ)
Title: A frame assembly including a connector and a hollow frame member
Inventor: JORNA JOANNES HENDRICUS
Filed: 2007-06-27
Abstract: A frame assembly is disclosed. The frame assembly includes a connector 11 and a hollow frame member 12, 13. The connector has at least one projection for receiving a complimentary end of the hollow frame member. The projection 17, 18 has raised portions 22 on an outer surface thereof with the projection being dimensioned relative to the hollow frame member such that during fitting of the hollow end of the frame member over the projection, the end of the frame is deformed about the projection so as to be internally engaged by the raised portions.
Patent NZ-556711-A (NZ)
Title: Infusion unit with handle having longitudinal fold line to enable use in two different modes
Inventor: BURCHARD JORN
IPC: B65D85/808
Filed: 2005-11-18
Abstract: The disclosure relates to an infusion unit comprising a bag part (21) which contains an infusion material, preferably tea leaves, and a handle (22) which is connected to the bag part (21). Said type of infusion unit can be improved in such a manner that it is suitable for preparing high-quality infusion drinks, in particular, for street vendors. According to the disclosure, the handle (22) is a plate-shaped element, made of, preferably, paper, cardboard or plastic, whereon the bag part (21) is directly secured such that it is seen in the direction of the elongate extension of the handle (22), and is arranged between opposite lying ends (23, 24) of the handle (22) such that the handle extends on both sides over the connection point of the handle (22) with the bag part (21) when the handle (22) and the bag part (21) are tilted against each other about 90 DEG . The unit also has a centrally located fold line (not shown) running along the longitudinal extent when viewed from ends 23 to 24 so as to enable the unit to be used in different modes of operation.
Patent NZ-560436-A (NZ)
Title: Method of producing proanthocyanidin oligomer
Inventor: NONAKA GEN-ICHIRO
IPC: A61K8/00
Filed: 2006-02-24
Abstract: Disclosed is a composition containing a proanthocyanidin oligomer to the terminal of which epicatechin (EC) has been bonded and reduced in the molecular weight, and a proanthocyanidin oligomer to the terminal of which epigallocatechin gallate (EGCG) has been bonded and reduced in the molecular weight, which is obtained by heating plant materials containing proanthocyanidin polymer with green tea or extract thereof in an acidic aqueous solution. The method for producing the above composition is also disclosed. Also disclosed is the use of the said proanthocyanidin oligomer in the production of a composition for the treatment/prevention of lifestyle related diseases caused by generation of reactive oxygen species and brain diseases or for prevention of aging.
Patent NZ-565066-A (NZ)
Title: Detecting fires by comparing a reference spectrum to a a current spectrum
Inventor: VIEIRA PEDRO MANUEL CORDOSO
IPC: G08B17/12
Filed: 2006-07-07
Abstract: Disclosed is a system for the automatic detection of forest fires through optic spectroscopy. The system comprises an optical system for the detection of the electromagnetic radiation originated from the observed horizon, composed of a mirror (1) with 360 degree rotation and azimuth adjustment, which redirects the light collected from the horizon. The mirror is mounted over the main lens of a telescope (2) with a modified eyepiece so that the light gathered is transmitted by means of an optical fiber (3). The automatic detection system further comprises a spectrometer (4) for carrying out the atmospheric chemical analysis from the electromagnetic radiation detected; an optical fiber for the optical connection between the spectrometer and the optical detection system; and an autonomous system for the analysis of the electromagnetic radiation spectra for identification of smoke originated from fires. The autonomous system identifies the smoke by comparison between the spectra measured at the moment and a reference spectra. A further system is included to determine the distance to the smoke by focusing the telescope at the location in the horizon where the intensity of the smoke signal is the greatest.
Patent NZ-565475-A (NZ)
Title: 2,4-diamino-pyrimidines used as aurora inhibitors
Inventor: ZAHN STEPHAN KARL
IPC: A61P35/00
Filed: 2006-06-30
Abstract: Provided are new 2,4-diamino-pyrimidine derivatives useful as aurora Ser/Thr kinase inhibitors. Further provided are methods of their use in the manufacture of medicaments to treatment and/or prevention of cancer, infections, inflammatory and autoimmune diseases. Also provided are combinations of the compounds with various cytostatic or cytotoxic cancer drugs.
Patent NZ-569496-A (NZ)
Title: Endotracheal tube and intubation system including same
Inventor: EFRATI SHAI
IPC: A61M16/04
Filed: 2006-12-05
Abstract: An endotracheal tube for mechanically ventilating patients is disclosed. The endotracheal tube comprises a distal end for insertion into the patient's airway, past the vocal chords, through the subglottal region, and into the patient's lung; and a proximal end for connection to a mechanical ventilator. The endotracheal tube further comprises a cuff at the distal end of the endotracheal? tube to be located in the subglottal region of the patient below the vocal chords, an inflating lumen for inflating the cuff, and a suction lumen having a suction inlet port leading from the outer surface of the endotracheal tube, and to be located in the subglottal region, for evacuating secretions and/or rinsing fluid from the subglottal region during the mechanical ventilation of the patient.; The distal end of the endotracheal tube is formed with an outer surface configuration effective to prevent blockage of the suction inlet port by the cuff or by tracheal mucosal tissue of the patient during a negative pressure condition in the suction lumen.
Patent NZ-574406-A (NZ)
Title: Human protein tyrosine phosphatase inhibitors and methods of use
Inventor: GRAY JEFFREY LYLE
IPC: A61P35/00
Filed: 2007-06-27
Abstract: Disclosed is a compound having the formula (I) e.g (S)-{ 4-[2-(S)-(4-Ethylthiazol-2-yl)-2-(2-phenylacetylamido)ethyl]phenyl} -sulfamic acid wherein R and Z are defined in the specification or a pharmaceutically acceptable salt thereof for treating a disease chosen from diabetic retinopathy, macular degeneration, cancer, sickle cell anemia, sarcoid, syphilis, pseudoxanthoma elasticum, Paget's disease, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis, mycobacterial infections, Lyme's disease, systemic lupus erythematosis, retinopathy of prematurity, Bales' disease, Behcet's disease, infections causing a retinitis or choroiditis, presumed ocular histoplasmosis, Best's disease, myopia, optic pits, Stargardt's disease, pars planitis, chronic retinal detachment, hyperviscosity syndrome, toxoplasmosis, trauma and post-laser complications, diseases associated with rubeosis, and proliferative vitreoretinopathy, Crohn's disease and ulcerative colitis, psoriasis, sarcoidosis, rheumatoid arthritis, hemangiomas, Osler-Weber-Rendu disease, or hereditary hemorrhagic telangiectasia, solid or blood borne tumors and acquired immune deficiency syndrome, skeletal muscle and myocardial ischemia, stroke, coronary artery disease, peripheral vascular disease, coronary artery disease.
Patent NZ-579513-A (NZ)
Title: Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
Inventor: METZ GUNTHER
IPC: A61K31/437
Filed: 2008-03-28
Abstract: Disclosed are imidazopyridine derivatives of formula (I) or enantiomers, diastereomers, tautomers, solvates or pharmaceutically acceptable salts thereof, wherein the substituents are defined within the specification. Also disclosed are the compounds of formula (I) for the treatment or prophylaxis of disorders, diseases or conditions responsive to the inactivation of the melanocortin-4 receptor.
Patent NZ-579945-A (NZ)
Title: Pyrido [2,3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
Inventor: BUHR CHRIS A
IPC: C07D471/04
Filed: 2008-04-11
Abstract: Disclosed herein are specific 6-heteroaryl substituted pyrido[2,3-d]pyrimidin-7-one compounds as defined in specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of phosphatidylinositol 3-kinase (PI3K) signalling pathways are therefore useful in the treatment of cancer, in particular breast cancer, colon cancer, rectal cancer, endometrial cancer, gastric carcinoma, glioblastoma, hepatocellular carcinoma, small cell lung cancer, non-small cell lung cancer, melanoma, ovarian cancer, cervical cancer, pancreatic cancer, prostate carcinoma, acute myelogenous leukemia (AML), chronic 15 myelogenous leukemia (CML), non-Hodgkin's lymphoma, or thyroid carcinoma.
Patent NZ-588438-A (NZ)
Title: Pyridin-2-yl oxadiazole derivatives as immunomodulating agents
Inventor: BOLLI MARTIN
IPC: A61K31/4245
Filed: 2009-02-25
Abstract: Disclosed are pyridine-2-yl compounds of formula (I) wherein the substituents are as defined in the specification, or salts thereof and their use in treating diseases associated with an activated immune system such as rejection of transplanted organs, autoimmune syndromes, inflammatory bowel diseases, thyroidistis and solid cancers.
Patent NZ-595532-A (NZ)
Title: Harpoon for attaching to a rotary wing aircraft, which is fired at, and retained in, an anchoring grate on a landing platform to assist in landing
Inventor: AFFRE DE SAINT ROME RONAN
IPC: B64B1/66
Filed: 2010-01-11
Abstract: An anchoring harpoon intended for an aircraft, capable of cooperating with an anchoring grate (2) of a platform, comprising jack means (3) including cylinder means (4) containing mobile piston means (5) provided with a rod (6) that extends beyond the cylinder means, the free end of which includes a harpoon head (7) that is hooked in the grate (2) and comprises retaining fingers (8, 13, 14) that can be moved between a retracted position and an active position by control means (9). The harpoon is characterised in that the cylinder means include at least two telescopic cylinder portions (10, 11) which can move between a position in which one portion is retracted inside the other and an active position in which one portion projects out from the other.
Patent NZ-596848-A (NZ)
Title: Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
Inventor: PIVETTI FAUSTO
IPC: A61K31/785
Filed: 2010-05-31
Abstract: 596848 IMPROVED RECONSTITUTED SURFACTANT COMPOSITION CONTAINING ANALOGS OF SURFACTANT PROTEIN B (SP-B) AND SURFACTANT PROTEIN C (SP-C) Provided is a reconstituted surfactant composition comprising: a) from 1.2 to 1.8% by weight of a functional fragment of the native surfactant protein SP-C consisting of the sequence represented by the formula IPSSPVHLKRLKLLLLLLLLILLLILGALLLGL; b) from 0.1 to 0.5% by weight of a functional fragment of the native surfactant protein SP-B consisting of the sequence represented by the formula CWLCRALIKRIQALIPKGGRLLPQLVCRLVLRCS; c) a monounsaturated and a saturated phospholipid in a weight ratio ranging from 45:55 to 55:45 wherein said monounsaturated phospholipid is selected from the group consisting of palmitoyloleoylphosphatidylcholine (POPC) and palmitoyloleoylphosphatidylglycerol (POPG) and wherein said saturated phospholipid is selected from the group consisting of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol (DPPG); all the amounts being calculated relative to the total weight of the reconstituted surfactant.
Patent NZ-597512-A (NZ)
Title: Novel fluorescent dyes and uses thereof
Inventor: WANG GUOPING
IPC: C09B57/00
Filed: 2010-07-15
Abstract: 597512 Disclosed are fluorescent dyes comprising a of the lucifern structure having a benzothiazole or benzoxazole core attached to a thiazole or oxazole moiety, according to the depicted compound. Specific examples of the fluorescent dyes include: 5-Trifluoromethyl-6-hydroxy dimethylluciferin N-hydroxysuccinimide ester, 5,7-Dimethyl-6-hydroxy dimethyl luciferin acid, and 5-Chloro-4-Hydroxy Luciferin Acid N-hydroxysuccinimide ester. Further disclosed is a dye conjugate comprising the fluorescent dye conjugated to another molecule such as a peptide or protein. Also disclosed is a method of detecting a complementary member of a specific binding pair in a sample by mixing the same with the fluorescent dye and detecting fluorescence change upon complexation.
Patent NZ-599954-A (NZ)
Title: Methods for producing hydrocarbon products from bio-oils and/or coal -oils
Inventor: MAXWELL IAN ERNEST
IPC: C10G1/00
Filed: 2010-10-27
Abstract: 599954 Disclosed is a method for producing a hydrocarbon product from coal comprising the following steps converting the coal to a coal-oil and using at least a portion of the bio-oil as a feedstock in a cracking reaction to convert hydrocarbon compounds in the feedstock into a mixture of smaller hydrocarbon compounds comprising the hydrocarbon product.
Patent NZ-600072-A (NZ)
Title: Improvements to a Taut Wire Fence System
Inventor: GALLAGHER IAN STUART
IPC: A01K3/00
Filed: 2010-05-24
Abstract: A connector (22) for a taut wire fence system is disclosed that is able to detect a change in force applied to the wire. The connector has a rigid main body member made in two parts (24, 25) having a first wire attachment at one end and a second wire or end support mount attachment at the opposite end. A sensor (37), configured to measure a change in a dimension of the main body member, is located between the first and the second attachments so that they are aligned and in substantially the same plane. The first attachment is electrically insulated from other parts of the connector.
Patent NZ-602478-A (NZ)
Title: Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
Inventor: BLAUGRUND ERAN
IPC: A61K31/47
Filed: 2011-03-02
Abstract: This disclosure provides a method of treating a subject afflicted with rheumatoid arthritis comprising periodically administering to the subject an amount of laquimmod or pharmaceutically acceptable salt thereof and an amount of methotrexate wherein the amounts when taken together are effective to treat the subject. This disclosure also provides laqumimod or pharmaceutically acceptable salt thereof for use in combination with methotrexate in treating a subject afflicted with rheumatoid arthritis. This disclosure also provides a pharmaceutical composition comprising an amount of laquimmod or pharmaceutically acceptable salt thereof and an amount of methotrexate for use in treating a subject afflicted with rheumatoid arthritis.
Patent NZ-602928-A (NZ)
Title: Anaerobic membrane bioreactor for treating a waste stream
Inventor: EWING JOHN
IPC: B01D61/22
Filed: 2011-04-13
Abstract: 602928 A waste stream having anaerobically biodegradable components is fed to an anaerobic reactor where the components react with microorganisms to biodegrade the components and produce biomass and biogas. Mixing occurs in select portions of the anaerobic reactor, particularly the bottom and top portions of the reactor. Relatively heavy solids settle to the bottom and are mixed with the mixed liquor while relatively light or fine solids float to the top portion of the anaerobic reactor where they are mixed with the mixed liquor. This leaves an intermediate or middle portion of the anaerobic reactor where the concentration of solids is relatively lower compared to the concentration of solids in the upper or lower portion of the anaerobic reactor.
Patent NZ-603579-A (NZ)
Title: Controlled release formulations
Inventor: ANDERSEN CHRISTINE
IPC: A61K9/20
Filed: 2010-06-23
Abstract: 603579 Disclosed herein is the use of a pharmaceutical composition in the manufacture of a medicament for treatment of chronic pain in an individual in need thereof, the pharmaceutical composition comprising: a) a matrix composition comprising i) 10 to 500 mg of an active drug substance, which is an analgesic; and ii) at least one polyglycol which is a homopolymer such as polyethylene glycol and/or a polyethylene oxide having a molecular weight of at least 20,000 daltons, said matrix composition having a cylindrical shape optionally with tapered end(s), the length of said matrix being shorter than 8 mm, said matrix being surrounded by b) a coating having one or two openings exposing at least one surface of said matrix, said coating being substantially impermeable to an aqueous medium, wherein said composition is formulated to be administered in a continuous schedule having a 5 to 20 hours interval between individual administrations. In one embodiment the composition further comprising at least one polygiycol, which is a copolymer such as a poloxamer.
Patent NZ-608480-A (NZ)
Title: A poultry house
Inventor: DUKER IAN DONALD
IPC: A01K31/22
Filed: 2011-12-22
Abstract: A poultry house (10) comprising a housing (11) and a run (14) coupled to the housing is disclosed. The housing is mounted for rotation about an axis (12) which extends upwardly from the ground on which the poultry house is located. The combined housing and run can be rotated about the axis and the position of the run thereby adjusted to prevent fouling of the ground.
Patent NZ-626283-A (NZ)
Title: Management of ethanol concentration during syngas fermentation
Inventor: SENARATNE RYAN
IPC: C12Q3/00
Filed: 2012-12-07
Abstract: A process for fermentation of syngas is disclosed where syngas is contacted with a medium inoculated with acetogenic bacteria and having a cell density of at least about 0.3 grams per litre. The syngas is fermented to convert CO to ethanol. Cells and medium are removed from the fermentation upon reaching an ethanol concentration of more than about 10 g/L in the fermentation. The removed cells and medium are separated to provide concentrated cells and permeate. Ethanol is separated from the permeate to provide ethanol and a reduced ethanol aqueous stream having less than about 5 weight % alcohol; and the reduced ethanol aqueous stream is provided having less than about 5 weight % alcohol to the fermentation. A ratio of a rate of providing the reduced ethanol aqueous stream to the fermentation to a rate of removing the cells and medium from the fermentation is about 5 to about 15 and an ethanol concentration of more than about 10 g/L is maintained in the fermentation.
Patent NZ-708533-A (NZ)
Title: Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose
Inventor: TRAN LAI
IPC: C12N1/04
Filed: 2013-11-29
Abstract: It can be difficult to maintain adequate probiotic viability when incorporating probiotics into nutritional supplements or foodstuffs. Preferred embodiments of the present invention seek to provide a protective matrix which may be used to enhance the viability of a probiotic distributed within it. In particular, the present invention relates to microparticles comprising a protective matrix and a protective matrix precursor composition comprising a blend of a denatured protein, a polyol plasticizer, trehalose and a carrier. The present invention provides a microparticle precursor composition comprising a blend of a probiotic, a cross-linkable reagent, a denatured protein, a polyol plasticizer, trehalose and a carrier. The present invention also provides a method of producing the microparticle precursor composition, a method of producing microparticles using the microparticle precursor composition, and microparticles produced using the microparticle precursor composition.
Patent NZ-719744-A (NZ)
Title: Multiple bit hand tool
Inventor: CLUTHE GARY PAUL
IPC: B25G1/08
Filed: 2014-10-28
Abstract: The disclosure is directed at a multiple bit hand tool. The hand tool includes a chuck portion that includes a locking collar mounted to handle body portion. The locking collar includes a latch portion including a set of latch arms, each latch arm having a bit end cap contact and a release cam contact, whereby when a tool bit is extended through the locking collar, the bit end cap contact abuts the tool bit to protect against retraction of the tool bit. The locking collar provides an improvement over the prior art in that there is an improved apparatus for protecting against the tool bit retracting during use of the hand tool.
Patent NZ-720335-A (NZ)
Title: Patient interface and method for making same
Inventor: SMART GREGORY SCOTT
IPC: A61M16/06
Filed: 2014-11-14
Abstract: A patient interface to deliver pressurized gas to a patient to treat sleep disordered breathing, the patient interface comprising: a seal-forming structure having a nasal opening to provide pressurized gas to both nares of the patient, and the seal-forming structure being configured to seal around an inferior periphery of the patient’s nose and at or near the tip of the patient’s nose; a plenum chamber formed in one piece with the seal-forming structure, the plenum chamber including a plenum connection region; a frame releasably attachable to the plenum connection region; a connection port formed in one piece with the frame; and a gas delivery tube permanently joined to the frame at the connection port, the gas delivery tube comprising a helical coil comprised of a plurality of adjacent coils, each coil separated by a width and having an outer surface forming a coil diameter, wherein the seal-forming structure comprises a pair of protruding ends extending symmetrically about the nasal opening, each protruding end configured to seal against a region of the patient’s face where the ala of the patient’s nose joins to the patient’s face, wherein the seal-forming structure comprises a pair of protruding end support sections, each of the pair of protruding end support sections extending into a gas chamber formed at least in part by the seal-forming structure and the plenum chamber to support a corresponding protruding end, and wherein each protruding end support section comprises a solid projection extending into the gas chamber in cantilever fashion.
Patent NZ-741955-A (NZ)
Title: Dendritic cell composition
Inventor: SCHENDEL DOLORES
IPC: C12N5/0784
Filed: 2016-12-22
Abstract: The present invention contemplates dendritic cell compositions. The dentritic cell compositions employ MHC class-II targeting signals fused to an antigen or fragment thereof to obtain MHC II presentation of the antigen or fragment thereof. In particular, the invention refers to a dendritic cell vaccine comprising dendritic cells expressing a MHC class-II targeting signal fused to an antigen or fragment thereof in combination with dendritic cells expressing the same antigen that is not fused to said signal. Dendritic cell vaccines for the stimulation of an immune response against melanoma-associated antigen are also described.
Patent NZ-746623-A (NZ)
Title: Apparatus for receiving smokable material
Inventor: MEHNERT JOHN CLAY
IPC: A24F40/20
Filed: 2017-05-12
Abstract: Apparatus [10] for receiving smokable material to enable at least one component of the smokable material to be volatilised is described.In an example, the apparatus comprises a housing [14] having a first compartment [38] and a second compartment [60]. The first compartment [38] is a heating compartment for receiving smokable material in use. The second compartment [60] is an electronics compartment and containing at least one of control circuitry [21] and a power source [22]. The first compartment [38] and the second compartment [60] are substantially hermetically sealed from each other to minimise or prevent air or vapour flowing between the compartments [38, 60].